James A. Mastrianni to Gerstmann-Straussler-Scheinker Disease
This is a "connection" page, showing publications James A. Mastrianni has written about Gerstmann-Straussler-Scheinker Disease.
Connection Strength
2.125
-
"Dual Disease" TgAD/GSS mice exhibit enhanced Alzheimer's disease pathology and reveal PrPC-dependent secretion of Aß. Sci Rep. 2019 06 12; 9(1):8524.
Score: 0.678
-
Rapamycin delays disease onset and prevents PrP plaque deposition in a mouse model of Gerstmann-Sträussler-Scheinker disease. J Neurosci. 2012 Sep 05; 32(36):12396-405.
Score: 0.424
-
A New Transgenic Mouse Model of Gerstmann-Straussler-Scheinker Syndrome Caused by the A117V Mutation of PRNP. J Neurosci. 2009 Aug 12; 29(32):10072-80.
Score: 0.343
-
Anle138b prevents PrP plaque accumulation in Tg(PrP-A116V) mice but does not mitigate clinical disease. J Gen Virol. 2019 06; 100(6):1027-1037.
Score: 0.168
-
IVIG Delays Onset in a Mouse Model of Gerstmann-Sträussler-Scheinker Disease. Mol Neurobiol. 2019 Apr; 56(4):2353-2361.
Score: 0.159
-
The prion diseases: Creutzfeldt-Jakob, Gerstmann-Sträussler-Scheinker, and related disorders. J Geriatr Psychiatry Neurol. 1998; 11(2):78-97.
Score: 0.153
-
The prion diseases. J Geriatr Psychiatry Neurol. 2010 Dec; 23(4):277-98.
Score: 0.093
-
Amyotrophy in prion diseases. Arch Neurol. 2000 Jan; 57(1):33-8.
Score: 0.044
-
The prion diseases. Semin Neurol. 2000; 20(3):337-52.
Score: 0.044
-
A transmembrane form of the prion protein in neurodegenerative disease. Science. 1998 Feb 06; 279(5352):827-34.
Score: 0.010
-
Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein. Cell. 1995 Oct 06; 83(1):79-90.
Score: 0.008